Intended for healthcare professionals

  1. Research
  2. Use of N...
  3. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study
CCBYNC Open access
Research

Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3851 (Published 12 September 2018) Cite this as: BMJ 2018;362:k3851

Linked editorial

Regulatory response to contaminated valsartan

Linked opinion

Fast-tracked pharmacoepidemiology in drug safety issues

Data supplement

  • Web extra

Related articles

EditorialRegulatory response to contaminated valsartan

See more

Cited by...

  • The Medical Impact of Emergent Banning of N-nitrosodimethylamine (NDMA)- contaminated Antihypertensive Drug: A nationwide longitudinal cohort study
  • Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort Study
  • Cancer risk from nitrosamine-contaminated valsartan
  • The quality of medical products for cardiovascular diseases: a gap in global cardiac care
  • What is the significance of nitrosamine contamination in medicines?
  • Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed mice
  • Regulatory response to contaminated valsartan
Back to top